𝔖 Bobbio Scriptorium
✦   LIBER   ✦

African-American/White differences in breast carcinoma : p53 alterations and other tumor characteristics

✍ Scribed by Andrew K. Joe; Hanina Hibshoosh


Book ID
102109262
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
65 KB
Volume
104
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


African-American/White differences in br
✍ Beth A. Jones; Stanislav V. Kasl; Christine L. Howe; Mary Lachman; Robert Dubrow πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 105 KB

## Abstract ## BACKGROUND Despite mounting evidence that breast tumors in African‐American (AA) women are more aggressive compared with breast tumors in white (W) women, little is known regarding racial/ethnic differences in genetic alterations that may be of prognostic importance. ## METHODS In

Breast carcinoma tumor characteristics i
✍ Joann G. Elmore; Victoria M. Moceri; Darryl Carter; Eric B. Larson πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

A significant disparity in mortality rates exists between black and white patients with breast carcinoma. This study was designed to compare breast carcinoma tumor characteristics by race and to examine the possible reasons for these differences. ## METHODS. Female patients with an initial diagnosi

Reproductive factors and risk of breast
✍ Giske Ursin; Leslie Bernstein; Yaping Wang; Sarah J. Lord; Dennis Deapen; Jonath πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Few studies have investigated the association between reproductive factors and the risk of breast carcinoma among African‐American women. The authors assessed whether the number of full‐term pregnancies, age at first full‐term pregnancy, and total duration of breastfeedin

Breast carcinoma in African-American and
✍ Lisa A. Newman πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 55 KB πŸ‘ 1 views

The door to improved understanding of ethnicity‐related variations in breast carcinoma risk and outcome has now been wedged open by the powerful tools of molecular biology. It is the responsibility of clinicians and investigators to accept the challenge of conducting the studies, collecting and inte